KOPRAN - Kopran | Wealthrox

Kopran

KOPRAN · Pharma > Pharmaceuticals & Drugs · Chairman: Susheel G Somani Listing date: Nov. 26, 1994 · Employees: 348 · Mumbai · http://www.kopran.com

Stock Price vs Company Growth

5.2%

10.0%

24.1%

0.9%

32.9%

22.6%

49.2%

10y

13.8%

all

9.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 200 5.2%

157

216

Company Overview

Sales

643 Cr

Growth: 8.9%

Profit after Tax

47.5 Cr

Growth: -10.2%

Small Cap

963 Cr

P/E: 20.3x

Industry P/E: 29.6x

Fundamentals

Sales (Cr)	₹ 643
Growth	8.9%
EBITDA	11.6%
P/S	1.5x
Dividend	1.0%
P/E	20.3x
Book Value	₹ 108
PEG Ratio	2.2x
ROE	9.4%
P/B	1.8x

Shareholding Pattern

Institutions

Rikeen Pradip Dalal

1.24 %

Promoters

Oricon Enterprises Limited

13.91 %

Panorama Finvest Pvt.Ltd.

8.79 %

Sarvamangal Mercantile Co.Ltd.

6.71 %

Rajendra Somani

5.37 %

Susheel Somani

2.02 %

Others

Increase Decrease No change

Company Profile Detailed

The company was incorporated on April 26, 1958 as a private limited company under the name Kopran Chemical Company Pvt. Ltd. by Ramanlal V Shah Sevantilal, A Shah , Chimanlal G Sheth and Jivanalal M Shah. In 1972, the company’s management was acquired by Chemo Pharma Laboratories Ltd and the Company’s products were marketed by them.Promoted by the Parijat Enterprises, Kopran is currently an integrated health care company.

Belongs to (4 Indices)

Investors (63)

kopran.l...

modern.t...

oricon.e...

Followers (3)

sudheer....

lalit8

kunal9